Literature DB >> 15694839

Uptake and utilization of nucleosides for energy repletion.

Michela Giannecchini1, Marco Matteucci, Rossana Pesi, Francesco Sgarrella, Maria Grazia Tozzi, Marcella Camici.   

Abstract

In this paper, we report that cells undergoing metabolic stress conditions may use the ribose moiety of nucleosides as energy source to slow down cellular damage. In fact, the phosphorolytic cleavage of the N-glycosidic bond of nucleosides generates, without energy expense, the phosphorylated pentose, which through pentose phosphate pathway and glycolysis, can be converted to energetic intermediates. In this respect, nucleosides may be considered as energy source, alternative or supplementary to glucose, which may become of primary importance especially in conditions of cellular stress. In accordance with the role of these compounds in energy repletion, we also show that the uptake of nucleosides is increased when the energetic demand of the cell is enhanced. As cell model, we have used a human colon carcinoma cell line, LoVo, and the depletion of ATP, with a concomitant fall in the cell energy charge, has been induced by exclusion of glucose from the medium and pre-incubation with oligomycin, an inhibitor of oxidative phosphorylation. In these conditions of energy starvation, we show that the uptake of 2'-deoxyadenosine in LoVo cells is significantly enhanced, and that the phosphorylated ribose moiety of inosine can be used for energy repletion through anaerobic glycolysis. Our data support previous reports indicating that the phosphorylated ribose stemming from the intracellular catabolism of nucleosides may be used in eukaryots as energy source, and advance our knowledge on the regulation of the uptake of nucleosides in eukaryotic cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15694839     DOI: 10.1016/j.biocel.2004.10.005

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  6 in total

1.  Invited Lectures : Overviews Purinergic signalling: past, present and future.

Authors: 
Journal:  Purinergic Signal       Date:  2006-05-15       Impact factor: 3.765

2.  Metabolomic analysis of serum and myocardium in compensated heart failure after myocardial infarction.

Authors:  M Dan McKirnan; Yasuhiro Ichikawa; Zheng Zhang; Alice E Zemljic-Harpf; Sili Fan; Dinesh Kumar Barupal; Hemal H Patel; H Kirk Hammond; David M Roth
Journal:  Life Sci       Date:  2019-02-05       Impact factor: 5.037

3.  The antidepressant-like effect of inosine in the FST is associated with both adenosine A1 and A 2A receptors.

Authors:  Manuella P Kaster; Josiane Budni; Marta Gazal; Mauricio P Cunha; Adair R S Santos; Ana Lúcia S Rodrigues
Journal:  Purinergic Signal       Date:  2013-04-25       Impact factor: 3.765

4.  Comparison of the effects of adenosine, inosine, and their combination as an adjunct to reperfusion in the treatment of acute myocardial infarction.

Authors:  Abdel Shafy; Vincent Molinié; Miguel Cortes-Morichetti; Vincent Hupertan; Nermine Lila; Juan C Chachques
Journal:  ISRN Cardiol       Date:  2012-03-14

5.  Unique Exercise Lactate Profile in Muscle Phosphofructokinase Deficiency (Tarui Disease); Difference Compared with McArdle Disease.

Authors:  Päivi Piirilä; Minna E Similä; Johanna Palmio; Tomi Wuorimaa; Emil Ylikallio; Satu Sandell; Petri Haapalahti; Lasse Uotila; Henna Tyynismaa; Bjarne Udd; Mari Auranen
Journal:  Front Neurol       Date:  2016-05-30       Impact factor: 4.003

Review 6.  The Inside Story of Adenosine.

Authors:  Marcella Camici; Mercedes Garcia-Gil; Maria Grazia Tozzi
Journal:  Int J Mol Sci       Date:  2018-03-09       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.